Trainee(Evidence on Medicinal Products for Endocrine/Cardiovascular Diseases in People with Obesity)

European Medicines Agency

Amsterdam, Noord-Holland
€ 1.964 per maand
Vast
Voltijds

29 dagen geleden

Selection procedure reference: EMA/TR/11125Deadline for applications: 30 September 2025 23:59 CETThe European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.This traineeship opportunity is now open for applications until 30 September 2025 23:59 CET, with an intake on 1 March 2026.About the traineeship programmeThe Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency's work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee's training and principally serve to increase the trainee's knowledge and to gain relevant experience.Placement descriptionWe are looking for a trainee in the Scientific Evidence Generation Department within Human Medicines Division.Specific objectives and projectsThis traineeship will provide the successful candidate with an opportunity to delve into the marketing authorisation dossiers of products for the treatment of obesity, diabetes, and cardiovascular disorders and answer some important questions for us.Obesity affects a significant portion of the general population and is a major risk factor for developing cardiovascular and endocrine diseases, such as type 2 diabetes, coronary heart disease, and stroke. Given this, medicinal products designed for the prevention and treatment of these conditions must be studied in populations affected by obesity or modelling should support dosing regimens in people living with obesity. Thus, alternative modelling approaches should be explored to understand how obesity influences the pharmacokinetics and pharmacodynamics of these treatments.
The altered body composition, changes in physiology, the presence of steatosis, and the chronic inflammation associated with obesity can significantly affect how a drug is absorbed, distributed, metabolized, and excreted in individuals with obesity compared to those without it.The main goal of this project is to evaluate the existing data that can inform the use of medicinal products in people living with obesity at the time of marketing authorization. We will focus primarily on products targeting diseases where people living with obesity make up a large portion of the patient population. The trainee will contribute to the design, data collection, and analysis of research examining the evidence base for these medicinal products in individuals living with obesity. Through this project, the trainee will also be involved in the regulatory and scientific activities of the Translational Sciences Office.Learning outcomesThrough this traineeship, the trainee will :

Gain an in-depth understanding of the European Medicines Agency's (EMA) approach to approving medicinal products for endocrine and cardiovascular diseases, including consideration of special populations and women's health.
Develop expertise in designing, implementing, and analyzing clinical studies, including pharmacokinetic and pharmacodynamic modeling.
Become familiar with regulatory requirements, agency processes, and regulatory practices related to medicinal products.

Eligibility criteriaTo be eligible for consideration for this placement, you are required to:

enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
possess a Master's degree of Sciences (or above) or a university degree in medicine, pharmacy, biomedical sciences, or any of the other life sciences (minimum of four years or more) that must have been obtained between 30 September 2024 and 30 September 2025 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.Additional skillsIn addition to the eligibility criteria, you will have:

excellent command of English
analytical skills
good understanding of clinical pharmacology
pharmacokinetics
understanding of and/or experience in modelling and simulation are considered beneficial

Behavioural CompetenciesYou will demonstrate the following behavioural competencies:

Communication skills
Interpersonal skills
Working with others
Adaptability
Research and analytical skills
Learning and development

Conditions of traineeshipThe traineeship is offered for 10 months (1 March 2026 - 31 December 2026) and takes place at the Agency's premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.The Agency pays a monthly stipend of €1,963.93 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.Each trainee will have a mentor at the Agency who will guide the trainee through the programme.The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available .Expected selection timelinesDeadline for applications 30 September 2025 23:59 CET
Assessments (remote) From mid-October 2025 to mid-November 2025
Decision and offers By end of November 2025
Placement start 1 March 2026Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The NetherlandsTelephone +31 (0)88 781 6000 - Email© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.Join us to work for every patient in Europe!Who we are?Serving a population of 500 million citizens, we promote and protect public animal health in EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality.What do we offer?

Meaningful work contributing to protecting the health of every individual and animal in Europe within multinational, multidisciplinary team
Development opportunities (e.g. internal mobility, mentoring, peer coaching, career reflection programme, etc.)
Work-life balance (flexible working arrangements, teleworking, generous annual leave plus official holidays)

Benefits(applicable only to Temporary and Contract vacancies)

Initial 5 year contract with competitive monthly tax-free salary and household & children’s allowances (where applicable)
Privileges for expatriate staff including expatriation and education allowances (where appropriate) and additional home leave
Relocation assistance
Excellent health insurance scheme and social benefits
Retirement Pension Plan